主题 - 关于米利珠单抗（溃疡性结肠炎，既往接受过治疗的患者）效益评估的声明，自 2023 年 11 月 06 日起生效

{"title":"主题 - 关于米利珠单抗（溃疡性结肠炎，既往接受过治疗的患者）效益评估的声明，自 2023 年 11 月 06 日起生效","authors":"","doi":"10.1055/a-2228-7793","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":327918,"journal":{"name":"Zeitschrift für Gastroenterologie","volume":"31 4","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Themen – Stellungnahme zur Nutzenbewertung von Mirikizumab (Colitis ulcerosa, vorbehandelte Patient*innen) vom 06. November 2023\",\"authors\":\"\",\"doi\":\"10.1055/a-2228-7793\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":327918,\"journal\":{\"name\":\"Zeitschrift für Gastroenterologie\",\"volume\":\"31 4\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Zeitschrift für Gastroenterologie\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2228-7793\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zeitschrift für Gastroenterologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/a-2228-7793","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}